{rfName}
Di

Indexed in

License and use

Altmetrics

Analysis of institutional authors

Garcia-Mulero, SAuthor
Share
Publications
>
Article

Differences in genome, transcriptome, miRNAome, and methylome in synchronous and metachronous liver metastasis of colorectal cancer

Publicated to:Frontiers In Oncology. 13 1133598- - 2023-04-27 13(), DOI: 10.3389/fonc.2023.1133598

Authors: Horak, J; Kubecek, O; Siskova, A; Honkova, K; Chvojkova, I; Krupova, M; Manethova, M; Vodenkova, S; García-Mulero, S; John, S; Cecka, F; Vodickova, L; Petera, J; Filip, S; Vymetalkova, V

Affiliations

Charles Univ Prague, Fac Med 3, Dept Med Genet, Prague, Czech Republic - Author
Charles Univ Prague, Fac Med Pilsen, Biomed Ctr, Plzen, Czech Republic - Author
Charles Univ Prague, Fac Med, Dept Oncol & Radiotherapy, Hradec Kralove, Czech Republic - Author
Charles Univ Prague, Fac Med, Dept Surg, Hradec Kralove, Czech Republic - Author
Charles Univ Prague, Inst Biol & Med Genet, Fac Med 1, Prague, Czech Republic - Author
Charles Univ Prague, Univ Hosp Hradec Kralove, Hradec Kralove, Czech Republic - Author
Czech Acad Sci, Dept Genet Toxicol & Epigenet, Inst Expt Med, Prague, Czech Republic - Author
Czech Acad Sci, Dept Mol Biol Canc, Inst Expt Med, Prague, Czech Republic - Author
Hosp Llobregat, Bellvitge Biomed Res Inst IDIBELL, Program Mol Mech & Expt Therapy Oncol Oncobell, Oncobell Programme, Barcelona, Spain - Author
Hosp Llobregat, Unit Biomarkers & Susceptibil,Oncol Data Analyt Pr, Catalan Inst Oncol ICO,Bellvitge Biomed Res Inst I, Oncobell Programme,Bellvitge Biomed Res Inst Oncob, Barcelona, Spain - Author
Univ Hosp Hradec Kralove, Fingerland Dept Pathol, Hradec Kralove, Czech Republic - Author
See more

Abstract

Keywords
Acaca geneAdjuvant therapyBevacizumabBim proteinBioconductor packageColorectal cancerFluoropyrimidineFluorouracilFolinic acidGene interactionGene mutationGenomeHepatectomyHistologyHspa1b geneHumanHuman cellHuman tissueIndel mutationIpo5 geneK ras proteinKaryopherinsKia1549l geneLiver metastasisManagementMechanismMed13l geneMetastatic colorectal cancerMethylomeMicroarray analysisMicrornaMicrorna 125b 2 3pMicrorna 126 3pMicrorna 1269 3pMicrorna 135b 3pMicrorna 135b 5pMicrorna 139 5pMicrorna 182 5pMicrorna 183 5pMicrorna 200a 5pMicrorna 200b 3pMicrorna 200b 5pMicrorna 200c 3pMicrorna 30c 1 3pMicrorna 365a 3pMicrorna 365b 3pMicrorna 429Microrna 455 3pMicrorna 483 5pMicrorna 548ah 3pMicrorna 548am 3pMicrorna 548pMicrorna 625 3pMicrorna 96 5pMicrorna 99a 3pMirnaomeMismatch repairMissense mutationMtor signalingMuc16 geneMultiple cancerNeurabin-iNucleotide binding oligomerization domain like receptorOncogene k rasOxaliplatinPcdha10 genePhosphatidylinositol 3,4,5 trisphosphate 3 phosphataseProspective studyProtein bcl 2Protein p53Prpf6 genePtprt geneRecurrence free survivalResectionRna isolationRna sequencingRyr2 geneSecond cancerSingle nucleotide polymorphismSyne1 geneTp53 geneTranscriptomeTransportTtn geneTumor mutational burdenUnclassified drugUpregulationUsh2a geneWhole exome sequencingWnt signaling

Quality index

Bibliometric impact. Analysis of the contribution and dissemination channel

The work has been published in the journal Frontiers In Oncology due to its progression and the good impact it has achieved in recent years, according to the agency WoS (JCR), it has become a reference in its field. In the year of publication of the work, 2023, it was in position 107/322, thus managing to position itself as a Q2 (Segundo Cuartil), in the category Oncology. Notably, the journal is positioned en el Cuartil Q2 para la agencia Scopus (SJR) en la categoría Oncology.

From a relative perspective, and based on the normalized impact indicator calculated from the Field Citation Ratio (FCR) of the Dimensions source, it yields a value of: 3.04, which indicates that, compared to works in the same discipline and in the same year of publication, it ranks as a work cited above average. (source consulted: Dimensions Apr 2025)

Specifically, and according to different indexing agencies, this work has accumulated citations as of 2025-04-29, the following number of citations:

  • WoS: 3
  • Scopus: 3
  • OpenCitations: 2
Impact and social visibility

From the perspective of influence or social adoption, and based on metrics associated with mentions and interactions provided by agencies specializing in calculating the so-called "Alternative or Social Metrics," we can highlight as of 2025-04-29:

  • The use, from an academic perspective evidenced by the Altmetric agency indicator referring to aggregations made by the personal bibliographic manager Mendeley, gives us a total of: 23.
  • The use of this contribution in bookmarks, code forks, additions to favorite lists for recurrent reading, as well as general views, indicates that someone is using the publication as a basis for their current work. This may be a notable indicator of future more formal and academic citations. This claim is supported by the result of the "Capture" indicator, which yields a total of: 23 (PlumX).

With a more dissemination-oriented intent and targeting more general audiences, we can observe other more global scores such as:

  • The Total Score from Altmetric: 2.25.
  • The number of mentions on the social network X (formerly Twitter): 4 (Altmetric).

It is essential to present evidence supporting full alignment with institutional principles and guidelines on Open Science and the Conservation and Dissemination of Intellectual Heritage. A clear example of this is:

  • The work has been submitted to a journal whose editorial policy allows open Open Access publication.
Leadership analysis of institutional authors

This work has been carried out with international collaboration, specifically with researchers from: Czech Republic.